T1	Participants 224 406	Each subject received a single oral dose (650 mg) of enteric-coated ASA (ecASA) and compressed ASA tablets (cASA), or ecASA and sodium salicylate (578 mg) separated by a minimum of 5
T2	Participants 198 222	12 healthy male subjects
